Clinical trial
Molecular Adsorbent Recirculating System (MARS®) for the Treatment of Patients With Hypoxic Hepatitis - a Prospective Randomized Controlled Clinical Study
NCT01690845 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Adsorbent Recirculating System (MARS®) for the Treatment of Patients With Hypoxic Hepatitis - a Prospective Randomized Controlled Clinical Study
- Lead sponsor
- Medical University of Vienna
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- June 30, 2012
- Completion date
- Not reported
- Enrollment
- 40 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
acute liver failure, hypoxic hepatitis, hypoxic liver injury, ischemic hepatitis, shock liver